SK Cell Applications in Skin Cancer Research

At Cytion, we provide various SK cell lines that have become instrumental in advancing skin cancer research. These well-characterized cell models, including SK-MEL-29.1, SK-MEL-2, and SK-MEL-28, serve as crucial tools for understanding melanoma biology and developing targeted therapies.

SK Melanoma Cell Lines in Research and Drug Development

SK melanoma cell lines represent essential tools in skin cancer research, with several key models available through Cytion. The SK-MEL-1 and SK-MEL-2 cell lines have been extensively used in fundamental research, while SK-MEL-28 has become particularly valuable in drug resistance studies.

Our research-validated SK melanoma lines are frequently employed in:

• Drug screening and development programs
• Signal transduction pathway analysis
• Resistance mechanism studies
• Therapeutic antibody development
• Cancer metabolism research

Notably, SK-MEL-29.1 cells have emerged as a powerful model for studying BRAF inhibitor resistance, a critical area in melanoma treatment development. These cells provide consistent and reproducible results, making them invaluable for both academic research and pharmaceutical development.

Modeling Melanoma Progression and Metastasis Using SK Cell Lines

SK melanoma cell lines from Cytion offer well-characterized models for investigating the complex processes of cancer progression and metastatic behavior. The SK-MEL-28 cell line, in particular, has become a gold standard for studying melanoma metastasis due to its consistent metastatic properties.

Key research applications include:

• Invasion assay development
• Metastatic cascade studies
• Tumor microenvironment interactions
• Epithelial-mesenchymal transition (EMT) research

Our comprehensive SK cell line panel, including SK-MEL-5 and SK-MEL-1, represents different stages of melanoma progression. This enables researchers to:

• Compare early versus late-stage melanoma characteristics
• Track changes in gene expression during disease progression
• Evaluate therapeutic responses at different disease stages
• Study metastatic site preferences

Genetic Profiles and Research Reproducibility

At Cytion, we ensure all SK melanoma cell lines undergo rigorous authentication and characterization. The SK-MEL-28 and SK-MEL-29.1 lines feature well-documented genetic profiles, including key mutations relevant to melanoma research.

Notable genetic characteristics include:

• BRAF V600E mutation status
• P53 pathway alterations
• MAPK pathway modifications
• PI3K/AKT pathway changes

To support research validity, we provide:

• Cell line authentication services
• Mycoplasma testing
• Detailed passage information
• Comprehensive genetic profiling data

Understanding Drug Resistance in Melanoma Through SK Cell Models

SK melanoma cell lines are invaluable tools for investigating drug resistance mechanisms. The SK-MEL-29.1 cells, available through Cytion, have been particularly instrumental in understanding BRAF inhibitor resistance, while SK-MEL-28 provides insights into multi-drug resistance patterns.

Key resistance studies enabled by our SK cell lines include:

• Development of resistance to targeted therapies
• Identification of resistance biomarkers
• Alternative pathway activation
• Cross-resistance mechanisms

Researchers can utilize our complementary cell lines such as A375 alongside SK melanoma cells to:

• Compare resistance mechanisms across different genetic backgrounds
• Validate therapeutic strategies
• Develop combination treatment approaches
• Study resistance reversal strategies

In Vitro and In Vivo Applications of SK Cell Lines

Cytion's SK melanoma cell lines demonstrate versatility across both in vitro and in vivo experimental settings. The SK-MEL-28 and SK-MEL-2 lines are particularly well-suited for translational research, offering reliable performance in multiple experimental contexts.

In Vitro Applications:

• 2D monolayer cultures for basic research
• 3D spheroid formation studies
• Co-culture experiments with immune cells
• High-throughput drug screening

In Vivo Applications:

• Xenograft tumor models
• Metastasis studies
• Drug efficacy testing
• Patient-derived xenograft (PDX) model development

For optimal results, we recommend using our specialized cell culture media and following our detailed protocols for both in vitro and in vivo applications.

To ensure experimental success, Cytion provides:

• Detailed culture protocols
• Technical support
• Quality assurance documentation
• Application-specific guidelines